ESR1 and breast cancer: It should be noted that the suppression of OCT-1 expression in the poorly invasive metastasizing triple-positive (estrogen receptor (ER)+, progesterone receptor (PR)+, HER2+) breast cancer MCF-7 cell line inhibits cell proliferation [46].